Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination

Read updated information about the use of antibody test results.

If your email program has trouble displaying this email, view as a webpage. Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination - FDA Safety Communication Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to remind health care providers and the public that results from currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person's level of immunity or protection from COVID-19 at any time, and especially after the person received a COVID-19 vaccination. This safety communication provides: Important recommendations for health care providers and the public. The FDA's actions to address the issue. Instructions to report problems with SARS-CoV-2 antibody tests to the FDA. Read More The FDA also updated the Serology/Antibody Tests: FAQs on Testing for SARS-CoV-2  and the Antibody (Serology) Testing for COVID-19: Information for Patients and Consumers web pages to provide updated information on the use of SARS-CoV-2 antibody test results. Questions? If you have questions about this safety communication, contact the Division of Industry and Consumer Education (DICE).

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA